Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Balagholi, Sahar, Dabbaghi, Rasul, Eshghi, Peyman, Mousavi, Seyed Asadollah, Heshmati, Farhad, Mohammadi, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605792/
https://www.ncbi.nlm.nih.gov/pubmed/33162341
http://dx.doi.org/10.1016/j.transci.2020.102993
Descripción
Sumario:Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopathogenesis and coagulopathy induced by SARS-CoV-2 and the potential benefits of TP as adjunctive treatment in critically COVID-19 patients.

Ejemplares similares